Sarcopenia is an independent risk factor for non-alcoholic steatohepatitis and significant fibrosis

References

Author names in bold designate shared co-first authorship.

1. • Chalasani N.
   • Younossi Z.
   • Lavine J.E.
   • Diehl A.M.
   • Brunt E.M.
   • Cusi K.
   • et al.
   The diagnosis and management of non-alcoholic fatty liver disease: practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association.
   Hepatology. 2012; 55: 2005-2023
   View in Article

   • Google Scholar
2. • Day C.P.
   • James O.F.
   Steatohepatitis: a tale of two “hits”?.
   Gastroenterology. 1998; 114: 842-845
   View in Article

   • Google Scholar
3. • Musso G.
   • Gambino R.
   • Cassader M.
   • Pagano G.
   Meta-analysis: natural history of non-alcoholic fatty liver disease (NAFLD) and diagnostic accuracy of non-invasive tests for liver disease severity.
   Ann Med. 2011; 43: 617-649
   View in Article

   • Google Scholar
4. • Rinella M.E.
   Nonalcoholic fatty liver disease: a systematic review.
   JAMA. 2015; 313: 2263-2273
   View in Article

   • Google Scholar
5. • Angulo P.
   • Kleiner D.E.
   • Dam-Larsen S.
   • Adams L.A.
   • Bjornsson E.S.
   • Charatcharoenwitthaya P.
   • et al.
   Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease.
   Gastroenterology. 2015; 149: e310
   View in Article

   • Google Scholar
6. • Kim D.
   • Kim W.
   • Kim H.J.
   • Therneau T.M.
   Association between noninvasive fibrosis markers and mortality among adults with nonalcoholic fatty liver disease in the United States.
   Hepatology. 2013; 57: 1357-1365
   View in Article

   • Google Scholar
7. • Treeprasertsuk S.
   • Björnsson E.
   • Enders F.
   • Suwanwalaikorn S.
   • Lindor K.D.
   NAFLD fibrosis score: a prognostic predictor for mortality and liver complications among NAFLD patients.
   World J Gastroenterol. 2013; 19: 1219-1229
   View in Article

   • Google Scholar
8. • Samuel V.T.
   • Liu Z.X.
   • Qu X.
   • Elder B.D.
   • Bilz S.
   • Befroy D.
   • et al.
   Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease.
   J Biol Chem. 2004; 279: 32345-32353
   View in Article

   • Google Scholar
9. • Lim S.
   • Kim J.H.
   • Yoon J.W.
   • Kang S.M.
   • Choi S.H.
   • Park Y.J.
   • et al.
   Sarcopenic obesity: prevalence and association with metabolic syndrome in the Korean Longitudinal Study on Health and Aging (KLoSHA).
   Diabetes Care. 2010; 33: 1652-1654
   View in Article

   • Google Scholar
10. • Lee S.W.
    • Youm Y.
    • Lee W.J.
    • Choi W.
    • Chu S.H.
    • Park Y.R.
    • et al.
    Appendicular skeletal muscle mass and insulin resistance in an elderly korean population: the korean social life, health and aging project-health examination cohort.
    Diabetes Metab J. 2015; 39: 37-45
    View in Article

    • Google Scholar
11. • Skov-Jensen C.
    • Skovbro M.
    • Flint A.
    • Helge J.W.
    • Dela F.
    Contraction-mediated glucose uptake is increased in men with impaired glucose tolerance.
    Appl Physiol Nutr Metab. 2007; 32: 115-124
    View in Article

    • Google Scholar
12. • Das K.
    • Das K.
    • Mukherjee P.S.
    • Ghosh A.
    • Ghosh S.
    • Mridha A.R.
    • et al.
    Nonobese population in a developing country has a high prevalence of nonalcoholic fatty liver and significant liver disease.
    Hepatology. 2010; 51: 1593-1602
    View in Article

    • Google Scholar
13. • Lee Y.H.
    • Jung K.S.
    • Kim S.U.
    • Yoon H.J.
    • Yun Y.J.
    • Lee B.W.
    • et al.
    Sarcopaenia is associated with NAFLD independently of obesity and insulin resistance: nationwide surveys (KNHANES 2008–2011).
    J Hepatol. 2015; 63: 486-493
    View in Article

    • Google Scholar
14. • Lee Y.H.
    • Kim S.U.
    • Song K.
    • Park J.Y.
    • Kim do Y.
    • Ahn S.H.
    • et al.
    Sarcopenia is associated with significant liver fibrosis independently of obesity and insulin resistance in nonalcoholic fatty liver disease: Nationwide surveys (KNHANES 2008–2011).
    Hepatology. 2016; 63: 776-786
    View in Article

    • Scopus (61)
    • Google Scholar
15. • Hong H.C.
    • Hwang S.Y.
    • Choi H.Y.
    • Yoo H.J.
    • Seo J.A.
    • Kim S.G.
    • et al.
    Relationship between sarcopenia and nonalcoholic fatty liver disease: the Korean Sarcopenic Obesity Study.
    Hepatology. 2014; 59: 1772-1778
    View in Article

    • Google Scholar
16. • Ryan C.K.
    • Johnson L.A.
    • Germin B.I.
    • Marcos A.
    One hundred consecutive hepatic biopsies in the workup of living donors for right lobe liver transplantation.
    Liver Transpl. 2002; 8: 1114-1122
    View in Article

    • Google Scholar
17. • Maximos M.
    • Bril F.
    • Portillo Sanchez P.
    • Lomonaco R.
    • Orsak B.
    • Biernacki D.
    • et al.
    The role of liver fat and insulin resistance as determinants of plasma aminotransferase elevation in nonalcoholic fatty liver disease.
    Hepatology. 2015; 61: 153-160
    View in Article

    • Google Scholar
18. • Ray Kim W.
    • Berg T.
    • Asselah T.
    • Flisiak R.
    • Fung S.
    • Gordon S.C.
    • et al.
    Evaluation of APRI and FIB-4 scoring systems for non-invasive assessment of hepatic fibrosis in chronic hepatitis B patients.
    J Hepatol. 2016; 64: 773-780
    View in Article

    • Google Scholar
19. • Hamaguchi M.
    • Kojima T.
    • Itoh Y.
    • Harano Y.
    • Fujii K.
    • Nakajima T.
    • et al.
    The severity of ultrasonographic findings in nonalcoholic fatty liver disease reflects the metabolic syndrome and visceral fat accumulation.
    Am J Gastroenterol. 2007; 102: 2708-2715
    View in Article

    • Google Scholar
20. • Torres D.M.
    • Harrison S.A.
    NAFLD: predictive value of ALT levels for NASH and advanced fibrosis.
    Nat Rev Gastroenterol Hepatol. 2013; 10: 510-511
    View in Article

    • Google Scholar
21. Obesity: preventing and managing the global epidemic. Report of a WHO consultation.
    World Health Organ Tech Rep Ser. 2000; 894: 1-253
    View in Article

    • Google Scholar
22. • Matthews D.R.
    • Hosker J.P.
    • Rudenski A.S.
    • Naylor B.A.
    • Treacher D.F.
    • Turner R.C.
    Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
    Diabetologia. 1985; 28: 412-419
    View in Article

    • Google Scholar
23. • American Diabetes Association
    Standards of medical care in diabetes – 2013.
    Diabetes Care. 2013; 36: S11-66
    View in Article

    • Google Scholar
24. • Rangel Peniche D.B.
    • Raya Giorguli G.
    • Aleman-Mateo H.
    Accuracy of a predictive bioelectrical impedance analysis equation for estimating appendicular skeletal muscle mass in a non-Caucasian sample of older people.
    Arch Gerontol Geriatr. 2015; 61: 39-43
    View in Article

    • Google Scholar
25. • Janssen I.
    • Heymsfield S.B.
    • Ross R.
    Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability.
    J Am Geriatr Soc. 2002; 50: 889-896
    View in Article

    • Google Scholar
26. • Kim K.M.
    • Lim S.
    • Choi S.H.
    • Kim J.H.
    • Shin C.S.
    • Park K.S.
    • et al.
    Cardiometabolic implication of sarcopenia: The Korea National Health and Nutrition Examination Study (KNHANES) 2008–2010.
    IJC Metab Endocr. 2014; 4: 63-69
    View in Article

    • Google Scholar
27. • Kim Y.S.
    • Lee Y.
    • Chung Y.S.
    • Lee D.J.
    • Joo N.S.
    • Hong D.
    • et al.
    Prevalence of sarcopenia and sarcopenic obesity in the Korean population based on the Fourth Korean National Health and Nutritional Examination Surveys.
    J Gerontol A Biol Sci Med Sci. 2012; 67: 1107-1113
    View in Article

    • Google Scholar
28. • Lee Y.H.
    • Kim J.E.
    • Roh Y.H.
    • Choi H.R.
    • Rhee Y.
    • Kang D.R.
    • et al.
    The combination of vitamin D deficiency and mild to moderate chronic kidney disease is associated with low bone mineral density and deteriorated femoral microarchitecture: results from the KNHANES 2008–2011.
    J Clin Endocrinol Metab. 2014; 99: 3879-3888
    View in Article

    • Google Scholar
29. • Studenski S.A.
    • Peters K.W.
    • Alley D.E.
    • Cawthon P.M.
    • McLean R.R.
    • Harris T.B.
    • et al.
    The FNIH sarcopenia project: rationale, study description, conference recommendations, and final estimates.
    J Gerontol A Biol Sci Med Sci. 2014; 69: 547-558
    View in Article

    • Google Scholar
30. • Brunt E.M.
    • Kleiner D.E.
    • Wilson L.A.
    • Belt P.
    • Neuschwander-Tetri B.A.
    • Network N.C.R.
    Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings.
    Hepatology. 2011; 53: 810-820
    View in Article

    • Google Scholar
31. • Brunt E.M.
    • Janney C.G.
    • Di Bisceglie A.M.
    • Neuschwander-Tetri B.A.
    • Bacon B.R.
    Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions.
    Am J Gastroenterol. 1999; 94: 2467-2474
    View in Article

    • Google Scholar
32. • Kleiner D.E.
    • Brunt E.M.
    • Van Natta M.
    • Behling C.
    • Contos M.J.
    • Cummings O.W.
    • et al.
    Design and validation of a histological scoring system for nonalcoholic fatty liver disease.
    Hepatology. 2005; 41: 1313-1321
    View in Article

    • Google Scholar
33. • Kwok R.
    • Tse Y.K.
    • Wong G.L.
    • Ha Y.
    • Lee A.U.
    • Ngu M.C.
    • et al.
    Systematic review with meta-analysis: non-invasive assessment of non-alcoholic fatty liver disease–the role of transient elastography and plasma cytokeratin-18 fragments.
    Aliment Pharmacol Ther. 2014; 39: 254-269
    View in Article

    • Google Scholar
34. • Park S.H.
    • Kim P.N.
    • Kim K.W.
    • Lee S.W.
    • Yoon S.E.
    • Park S.W.
    • et al.
    Macrovesicular hepatic steatosis in living liver donors: use of CT for quantitative and qualitative assessment.
    Radiology. 2006; 239: 105-112
    View in Article

    • Google Scholar
35. • Issa D.
    • Alkhouri N.
    • Tsien C.
    • Shah S.
    • Lopez R.
    • McCullough A.
    • et al.
    Presence of sarcopenia (muscle wasting) in patients with nonalcoholic steatohepatitis.
    Hepatology. 2014; 60: 428-429
    View in Article

    • Scopus (10)
    • Google Scholar
36. • Ballestri S.
    • Nascimbeni F.
    • Romagnoli D.
    • Lonardo A.
    The independent predictors of NASH and its individual histological features. Insulin resistance, serum uric acid, metabolic syndrome, ALT and serum total cholesterol are a clue to pathogenesis and candidate targets for treatment.
    Hepatol Res. 2016;
    View in Article

    • Google Scholar
37. • Liew P.L.
    • Lee W.J.
    • Lee Y.C.
    • Wang H.H.
    • Wang W.
    • Lin Y.C.
    Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease.
    Obes Surg. 2006; 16: 1584-1593
    View in Article

    • Google Scholar
38. • Lonardo A.
    • Sookoian S.
    • Pirola C.J.
    • Targher G.
    Non-alcoholic fatty liver disease and risk of cardiovascular disease.
    Metabolism. 2016; 65: 1136-1150
    View in Article

    • Google Scholar
39. • Singh S.
    • Khera R.
    • Allen A.M.
    • Murad M.H.
    • Loomba R.
    Comparative effectiveness of pharmacological interventions for nonalcoholic steatohepatitis: a systematic review and network meta-analysis.
    Hepatology. 2015; 62: 1417-1432
    View in Article

    • Google Scholar
40. • Armstrong M.J.
    • Gaunt P.
    • Aithal G.P.
    • Barton D.
    • Hull D.
    • Parker R.
    • et al.
    Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study.
    Lancet. 2016; 387: 679-690
    View in Article

    • Scopus (765)
    • Google Scholar
41. • Hallsworth K.
    • Fattakhova G.
    • Hollingsworth K.G.
    • Thoma C.
    • Moore S.
    • Taylor R.
    • et al.
    Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss.
    Gut. 2011; 60: 1278-1283
    View in Article

    • Google Scholar
42. • Bacchi E.
    • Negri C.
    • Targher G.
    • Faccioli N.
    • Lanza M.
    • Zoppini G.
    • et al.
    Both resistance training and aerobic training reduce hepatic fat content in type 2 diabetic subjects with nonalcoholic fatty liver disease (the RAED2 Randomized Trial).
    Hepatology. 2013; 58: 1287-1295
    View in Article

    • Google Scholar
43. • Zelber-Sagi S.
    • Buch A.
    • Yeshua H.
    • Vaisman N.
    • Webb M.
    • Harari G.
    • et al.
    Effect of resistance training on non-alcoholic fatty-liver disease a randomized-clinical trial.
    World J Gastroenterol. 2014; 20: 4382-4392
    View in Article

    • Google Scholar
44. • Chung G.E.
    • Kim D.
    • Kwark M.S.
    • Kim W.
    • Yim J.Y.
    • Kim Y.J.
    • et al.
    Visceral adipose tissue area as an independent risk factor for elevated liver enzyme in nonalcoholic fatty liver disease.
    Medicine (Baltimore). 2015; 94: e573
    View in Article

    • Google Scholar
45. • Kim D.
    • Chung G.E.
    • Kwak M.S.
    • Seo H.B.
    • Kang J.H.
    • Kim W.
    • et al.
    Body fat distribution and risk of incident and regressed nonalcoholic fatty liver disease.
    Clin Gastroenterol Hepatol. 2016; 14: e134
    View in Article

    • Scopus (1)
    • Abstract
    • Full Text
    • Full Text PDF
    • Google Scholar
46. • Yu S.J.
    • Kim W.
    • Kim D.
    • Yoon J.H.
    • Lee K.
    • Kim J.H.
    • et al.
    Visceral obesity predicts significant fibrosis in patients with nonalcoholic fatty liver disease.
    Medicine (Baltimore). 2015; 94: e2159
    View in Article

    • Scopus (27)
    • Google Scholar
47. • Fracanzani A.L.
    • Valenti L.
    • Bugianesi E.
    • Vanni E.
    • Grieco A.
    • Miele L.
    • et al.
    Risk of nonalcoholic steatohepatitis and fibrosis in patients with nonalcoholic fatty liver disease and low visceral adiposity.
    J Hepatol. 2011; 54: 1244-1249
    View in Article

    • Google Scholar
48. • Beyer I.
    • Mets T.
    • Bautmans I.
    Chronic low-grade inflammation and age-related sarcopenia.
    Curr Opin Clin Nutr Metab Care. 2012; 15: 12-22
    View in Article

    • Google Scholar
49. • Phillips T.
    • Leeuwenburgh C.
    Muscle fiber specific apoptosis and TNF-alpha signaling in sarcopenia are attenuated by life-long calorie restriction.
    FASEB J. 2005; 19: 668-670
    View in Article

    • Scopus (240)
    • Crossref
    • Google Scholar
50. • Payette H.
    • Roubenoff R.
    • Jacques P.F.
    • Dinarello C.A.
    • Wilson P.W.
    • Abad L.W.
    • et al.
    Insulin-like growth factor-1 and interleukin 6 predict sarcopenia in very old community-living men and women: the Framingham Heart Study.
    J Am Geriatr Soc. 2003; 51: 1237-1243
    View in Article

    • Google Scholar
51. • Ferrucci L.
    • Penninx B.W.
    • Volpato S.
    • Harris T.B.
    • Bandeen-Roche K.
    • Balfour J.
    • et al.
    Change in muscle strength explains accelerated decline of physical function in older women with high interleukin-6 serum levels.
    J Am Geriatr Soc. 2002; 50: 1947-1954
    View in Article

    • Google Scholar
52. • Tilg H.
    • Moschen A.R.
    Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis.
    Hepatology. 2010; 52: 1836-1846
    View in Article

    • Google Scholar
53. • Newman A.B.
    • Lee J.S.
    • Visser M.
    • Goodpaster B.H.
    • Kritchevsky S.B.
    • Tylavsky F.A.
    • et al.
    Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study.
    Am J Clin Nutr. 2005; 82 ([quiz 915–876]): 872-878
    View in Article

    • Scopus (301)
    • Google Scholar
54. • Hughes V.A.
    • Frontera W.R.
    • Roubenoff R.
    • Evans W.J.
    • Singh M.A.
    Longitudinal changes in body composition in older men and women: role of body weight change and physical activity.
    Am J Clin Nutr. 2002; 76: 473-481
    View in Article

    • Scopus (510)
    • Google Scholar
55. • Kim J.H.
    • Lim S.
    • Choi S.H.
    • Kim K.M.
    • Yoon J.W.
    • Kim K.W.
    • et al.
    Sarcopenia: an independent predictor of mortality in community-dwelling older Korean men.
    J Gerontol A Biol Sci Med Sci. 2014; 69: 1244-1252
    View in Article

    • Google Scholar
56. • Srikanthan P.
    • Hevener A.L.
    • Karlamangla A.S.
    Sarcopenia exacerbates obesity-associated insulin resistance and dysglycemia: findings from the National Health and Nutrition Examination Survey III.
    PLoS ONE. 2010; 5: e10805
    View in Article

    • Google Scholar
57. • Bosaeus I.
    • Wilcox G.
    • Rothenberg E.
    • Strauss B.J.
    Skeletal muscle mass in hospitalized elderly patients: comparison of measurements by single-frequency BIA and DXA.
    Clin Nutr. 2014; 33: 426-431
    View in Article

    • Google Scholar
58. • Dasarathy J.
    • Alkhouri N.
    • Dasarathy S.
    Changes in body composition after transjugular intrahepatic portosystemic stent in cirrhosis: a critical review of literature.
    Liver Int. 2011; 31: 1250-1258
    View in Article

    • Google Scholar
59. • Haffner S.M.
    • Miettinen H.
    • Stern M.P.
    The homeostasis model in the San Antonio Heart Study.
    Diabetes Care. 1997; 20: 1087-1092
    View in Article

    • Google Scholar
60. • Bonora E.
    • Targher G.
    • Alberiche M.
    • Bonadonna R.C.
    • Saggiani F.
    • Zenere M.B.
    • et al.
    Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.
    Diabetes Care. 2000; 23: 57-63
    View in Article

    • Google Scholar